Kidney Blood Press. Res. 2020 Jan 31
Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease.
Abbasi F, Moosaie F, Khaloo P, Dehghani Firouzabadi F, Fatemi Abhari SM, Atainia B, Ardeshir M, Nakhjavani M, Esteghamati A
This study was designed to evaluate the conflicting association between 2 tubular protein markers including neutrophil gelatinase-associated lipocalin ...
Read More
Source: PubMed
J Proteomics 2020 Jan 29
Differential analysis of urinary albumin for membranous nephropathy patients by online capillary isoelectric focusing - Mass spectrometry.
Tie C, Liu L, Feng T, Sa R, Xia Q, Liang H, Mao Y
Membranous nephropathy (MN) is one of the most common causes of primary glomerular diseases worldwide. The M-type phospholipase A2 receptor (PLA2R), a ...
Read More
Source: PubMed
J Integr Med 2020 Jan 16
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Shinjyo N, Parkinson J, Bell J, Katsuno T, Bligh A
A growing number of epidemiological studies indicate that metabolic syndrome (MetS) and its associated features play a key role in the development of ...
Read More
Source: PubMed
Nephrol. Dial. Transplant.
Sodium-glucose cotransporter 2 inhibitors: extending the indication to non-diabetic kidney disease?
Dekkers CCJ, Gansevoort RT
This year the medical community was pleasantly surprised by the results of the first large outcome trial that primarily examined the renal effects of ...
Read More
Source: PubMed
Nephrol. Dial. Transplant.
Renal physiology of glucose handling and therapeutic implications.
Cherney DZ, Kanbay M, Lovshin JA
The rationale for using sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes (T2D) has evolved over the last decade. Due ...
Read More
Source: PubMed
